( lysis is largely unprecedented in the t...)Combination of Tratuzumab and Chemotherapy Yields Better Results for Breast Cancer,Health

(Date:12/16/2009)... Ensure and Encourage Access to Quality, Cost-Effective Care , ... ... of Congress have debated the best ways to rein in runaway ... reform. An important part of the ongoing discussion includes how ... care providers besides doctors of medicine (MDs) or osteopathy (DOs). ...

(Date:12/16/2009)... the global leader of Digital Pen and Paper technology and ... clinical trials, today announced that it is ranked among the ... - EMEA 2009. , ... (PRWEB) ... software solutions for the capture, digitalization and management of handwritten ...

(Date:12/16/2009)... factor for use, expert says, , , WEDNESDAY, Dec. 16 ... much less likely to die when they receive an ... study included 4,685 people, ages 65 to 85, who ... ventricular fraction (a measure of the heart,s pumping ability) ... period, those who were treated with standard medication and ...

(Date:12/16/2009)... 16 Shoppers like knowing if their ... Argentina. But grocers have found it burdensome to ... laws requiring them to provide the information at ... easyCOOLnow.com for easily making grocery and ... provisions that require retailers of unprocessed fruits, vegetables ...

(Date:12/16/2009)... A new software program developed by CareRise will reduce ... calculate their staffing needs as it relates to the ... healthcare facilities to calculate their mandatory nurse-to-patient staffing needs, ... a daily report as to how it affects their ... risk management in the healthcare industry, has been allowed ...

... Innovations, Inc. (Nasdaq: YDNT ) today announced that it ... on-demand web cast conference call on Tuesday, April 28, 2009 at ... call will be available through InterCall at http://tinyurl.com/ydnt1QTR09 ... will also be available through the Company,s website, www.ydnt.com ...

... 20 The board of directors of Eli Lilly and ... for the second quarter of 2009 of $0.49 a share ... as was paid in the first quarter and maintains the ... dividend is payable June 10, 2009, to shareholders of record ...

... AMGN ) today announced that it plans to ... 2009 after the close of the financial markets. The announcement ... community at 2 p.m. Pacific Time. Participating in the ... executive officer, and other members of Amgen,s senior management team.Live ...

... study finds 8-ounce glass enhances absorption of rapamycin 3 to ... Grapefruit juice boosts the anti-cancer effects of the drug rapamycin, ... advanced solid tumors, for which there is no effective treatment. ... the drug, as a liquid, once a week. After the ...

... define advantages, limits of procedure, study suggests , , MONDAY, ... useful for removal of certain head and neck cancers, ... with oral cavity, throat or larynx tumors. Of those ... of the cancerous tissue. Negative margins (when no cancer ...

... Mass., April 20 Inverness Medical Innovations, Inc. (NYSE: ... take charge of their health at home through the merger ... will release its first quarter 2009 earnings on Monday, April ... beginning at 10:00 a.m. (Eastern Time) on that date to ...

(Date:12/16/2009)... 16 AVAX Technologies, Inc. (Pink Sheets: ... it recently closed a bridge loan financing (the ... Warrant Purchase Agreement (the "Agreement") with Firebird Global ... the Company sold a convertible promissory note, due ... of US$1,400,000, and issued a warrant to purchase ...

(Date:12/16/2009)... 16 Cohera Medical Inc. today announced ... study of its lead surgical adhesive product, TissuGlu®. ... in the company,s progression of the lead product ... is a prospective, open-label, randomized study to investigate ... wound drainage and associated complications in abdominoplasty, or ...

(Date:12/16/2009)... Verathon®, maker of BladderScan® bladder volume instruments ... volume ultrasound is now included in the ... of Catheter-Associated Urinary Tract Infections (CA-UTIs). ... November 2009, replace the previous guidelines which ... are located on the Web at: ...

... Efficacy of LBH589 in ... Myeloma, NORWALK, Conn., Aug. 14 The Multiple ... Phase II,study to determine the efficacy of LBH589 for ... LBH589 is an orally,administered deacetylase inhibitor developed by Novartis ...

... WESTMINSTER, Colo., Aug. 15 Allos,Therapeutics, Inc. (Nasdaq: ... patient,enrollment in a Phase 1, open-label, multi-center study ... B12 and folic acid,supplementation in patients with relapsed ... our experience with PDX in patients with peripheral ...

... Unparalleled Comfort Pick one of our pipettors ... the trigger and ejector positionsright where they should ... are ergonomically designed to help avoid repetitive stress ... Productivity In The Palm Of Your Hand ...

... Pick one of our pipettors up and ... and ejector positionsright where they should beeven if ... designed to help avoid repetitive stress injuries caused ... The Palm Of Your Hand Start dispensing ...

... BioControl multichannel has the same ... channel model. The same universal ... and five single channel tip ... a recharge and storage stand ...

... The Research pro Electronic Pipette is ... the laboratory. Its easy-to-follow display, ergonomically-placed operating ... pipetting, dispensing, reverse pipetting and diluting make ... the simple functions of a manual pipette ...